Levens NR - Search Results

1

Neuropeptide Y2 receptors as drug targets for the central regulation of body weight.

Félétou M, Levens NR. Félétou M, et al. Among authors: levens nr. Curr Opin Investig Drugs. 2005 Oct;6(10):1002-11. Curr Opin Investig Drugs. 2005. PMID: 16259221 Review.

2

NPY receptors as drug targets for the central regulation of body weight.

Félétou M, Galizzi JP, Levens NR. Félétou M, et al. Among authors: levens nr. CNS Neurol Disord Drug Targets. 2006 Jun;5(3):263-74. doi: 10.2174/187152706777452236. CNS Neurol Disord Drug Targets. 2006. PMID: 16787228 Review.

3

Appetite suppression based on selective inhibition of NPY receptors.

Chamorro S, Della-Zuana O, Fauchère JL, Félétou M, Galizzi JP, Levens N. Chamorro S, et al. Int J Obes Relat Metab Disord. 2002 Mar;26(3):281-98. doi: 10.1038/sj.ijo.0801948. Int J Obes Relat Metab Disord. 2002. PMID: 11896483 Review.

4

Reduced food intake in response to CGP 71683A may be due to mechanisms other than NPY Y5 receptor blockade.

Della Zuana O, Sadlo M, Germain M, Félétou M, Chamorro S, Tisserand F, de Montrion C, Boivin JF, Duhault J, Boutin JA, Levens N. Della Zuana O, et al. Int J Obes Relat Metab Disord. 2001 Jan;25(1):84-94. doi: 10.1038/sj.ijo.0801472. Int J Obes Relat Metab Disord. 2001. PMID: 11244462

5

A potent and selective NPY Y5 antagonist reduces food intake but not through blockade of the NPY Y5 receptor.

Della-Zuana O, Revereault L, Beck-Sickinger A, Monge A, Caignard DH, Fauchère JL, Henlin JM, Audinot V, Boutin JA, Chamorro S, Félétou M, Levens N. Della-Zuana O, et al. Int J Obes Relat Metab Disord. 2004 Apr;28(4):628-39. doi: 10.1038/sj.ijo.0802435. Int J Obes Relat Metab Disord. 2004. PMID: 14758341

6

Differential effects of sulphonylureas on the vasodilatory response evoked by K(ATP) channel openers.

Ravel D, Levens N, Félétou M, Néliat G, Auclair J, Bouskela E. Ravel D, et al. Fundam Clin Pharmacol. 2003 Feb;17(1):61-9. doi: 10.1046/j.1472-8206.2003.00144.x. Fundam Clin Pharmacol. 2003. PMID: 12588631

7

Endothelin-1 inhibits TNF alpha-induced iNOS expression in 3T3-F442A adipocytes.

Mérial-Kieny C, Lonchampt M, Cogé F, Verwaerde P, Galizzi JP, Boutin JA, Lafontan M, Levens N, Galitzky J, Félétou M. Mérial-Kieny C, et al. Br J Pharmacol. 2003 Jul;139(5):935-44. doi: 10.1038/sj.bjp.0705325. Br J Pharmacol. 2003. PMID: 12839867 Free PMC article.

8

A diffusible substance(s) mediates endothelium-dependent contractions in the aorta of SHR.

Yang D, Félétou M, Levens N, Zhang JN, Vanhoutte PM. Yang D, et al. Hypertension. 2003 Jan;41(1):143-8. doi: 10.1161/01.hyp.0000047651.45322.16. Hypertension. 2003. PMID: 12511544

9

Oxygen-derived free radicals mediate endothelium-dependent contractions to acetylcholine in aortas from spontaneously hypertensive rats.

Yang D, Félétou M, Boulanger CM, Wu HF, Levens N, Zhang JN, Vanhoutte PM. Yang D, et al. Br J Pharmacol. 2002 May;136(1):104-10. doi: 10.1038/sj.bjp.0704669. Br J Pharmacol. 2002. PMID: 11976274 Free PMC article.

10

Protein tyrosine phosphatase 1B inhibitors for the treatment of type 2 diabetes and obesity: recent advances.

Harley EA, Levens N. Harley EA, et al. Curr Opin Investig Drugs. 2003 Oct;4(10):1179-89. Curr Opin Investig Drugs. 2003. PMID: 14649209 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters